Daniele Santini

Pubblicazioni

Titolo Pubblicato in Anno
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective analysis of progression-free (PFS) and overall survival (OS) in the “Real Life” ANNALS OF ONCOLOGY 2015
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety EUROPEAN JOURNAL OF CANCER 2015
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: results of an Italian multicentre study EUROPEAN UROLOGY 2015
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2015
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions BLOOD 2015
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs) ANNALS OF ONCOLOGY 2015
Targeted therapies for bone metastases Targeted Therapies for Solid Tumors 2015
Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients ANNALS OF ONCOLOGY 2015
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) ANNALS OF ONCOLOGY 2015
Targeted therapies for bone metastases Targeted Therapies for Solid Tumors 2015
Interventional radiologist's perspective on the management of bone metastatic disease EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2015
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence BREAST CANCER RESEARCH 2015
Emerging kinase inhibitors of the treatment of gastric cancer EXPERT OPINION ON EMERGING DRUGS 2015
Deregulation of dicer and mir-155 expression in liposarcoma ONCOTARGET 2015
Tissue invasion and metastasis: Molecular, biological and clinical perspectives SEMINARS IN CANCER BIOLOGY 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy TARGETED ONCOLOGY 2015
Percutaneous long bone cementoplasty for palliation of malignant lesions of the limbs: a systematic review CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY 2015
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter CURRENT ONCOLOGY 2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis PLOS ONE 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma